Search

Your search keyword '"Ingelsson, Martin"' showing total 1,585 results

Search Constraints

Start Over You searched for: Author "Ingelsson, Martin" Remove constraint Author: "Ingelsson, Martin"
1,585 results on '"Ingelsson, Martin"'

Search Results

104. CRISPR-Cas9 treatment partially restores amyloid-β 42/40 in human fibroblasts with the Alzheimer’s disease PSEN1 M146L mutation

107. Modeling Parkinson's disease-related symptoms in alpha-synuclein overexpressing mice

108. Reduction of alpha SYN Pathology in a Mouse Model of PD Using a Brain-Penetrating Bispecific Antibody

109. VALZ-Pilot : High-dose valacyclovir treatment in patients with early-stage Alzheimer's disease

110. Mixed Pathologies in a Subject with a Novel PSEN1 G206R Mutation

111. A beta and tau prions feature in the neuropathogenesis of Down syndrome

112. Supplemental Online Content. Association of Rare APOE Missense Variants V236E and R251G With Risk of Alzheimer Disease

113. Genome-wide meta-analysis for Alzheimer's disease cerebrospinal fluid biomarkers

114. Stroke genetics informs drug discovery and risk prediction across ancestries

115. Challenges at the APOE locus:a robust quality control approach for accurate APOE genotyping

116. The G51D SNCA mutation generates a slowly progressive α-synuclein strain in early-onset Parkinson's disease.

119. Protective association of HLA-DRB1*04 subtypes in neurodegenerative diseases implicates acetylated tau PHF6 sequences

120. Size matters - the impact of nucleus size on results from spatial transcriptomics

123. Additional file 1 of Challenges at the APOE locus: a robust quality control approach for accurate APOE genotyping

126. ABBV-0805, a novel antibody selective for soluble aggregated α-synuclein, prolongs lifespan and prevents buildup of α-synuclein pathology in mouse models of Parkinson's disease

128. MUTAGENESIS: Smoking is associated with mosaic loss of chromosome Y

130. Aβ and tau prions feature in the neuropathogenesis of Down syndrome.

131. The Uppsala APP deletion causes early onset autosomal dominant Alzheimer’s disease by altering APP processing and increasing amyloid β fibril formation

134. Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease

135. Additional file 12 of Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinson’s disease

136. Amyloid, tau, and astrocyte pathology in autosomal-dominant Alzheimer's disease variants : A beta PParc and PSEN1DE9

137. Differential DNA methylation of the genes for amyloid precursor protein, tau and neurofilaments in human traumatic brain injury

138. Large-scale plasma protein profiling of incident myocardial infarction, ischemic stroke, and heart failure

139. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

140. Impact of risk factors for major cardiovascular diseases : a comparison of life-time observational and Mendelian randomisation findings.

141. Accumulation of alpha-synuclein within the liver, potential role in the clearance of brain pathology associated with Parkinsons disease

142. ABBV-0805, a novel antibody selective for soluble aggregated alpha-synuclein, prolongs lifespan and prevents buildup of alpha-synuclein pathology in mouse models of Parkinson's disease

143. In vivo imaging of synaptic density with [C-11]UCB-J PET in two mouse models of neurodegenerative disease

144. The Uppsala APP deletion causes early onset autosomal dominant Alzheimer's disease by altering APP processing and increasing amyloid beta fibril formation

145. The existence of A beta strains and their potential for driving phenotypic heterogeneity in Alzheimer's disease

146. Different Inflammatory Signatures in Alzheimer's Disease and Frontotemporal Dementia Cerebrospinal Fluid

147. Life-Time Covariation of Major Cardiovascular Diseases : A 40-Year Longitudinal Study and Genetic Studies

148. Multi‐cohort profiling reveals elevated CSF levels of brain‐enriched proteins in Alzheimer’s disease

149. Common variants in Alzheimer's disease and risk stratification by polygenic risk scores

Catalog

Books, media, physical & digital resources